The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer

被引:15
|
作者
Ostheimer, Christian [1 ]
Schweyer, Franziska [1 ]
Reese, Thomas [1 ]
Bache, Matthias [1 ]
Vordermark, Dirk [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Radiat Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany
关键词
NSCLC; osteopontin; radiotherapy; tumor volume; prognostic factors; RADIATION-THERAPY; PROGNOSTIC-FACTOR; NECK-CANCER; HYPOXIA MARKERS; SURVIVAL; HEAD; CHEMORADIOTHERAPY; OXYGENATION; EXPRESSION; VELOCITY;
D O I
10.3892/ol.2016.5104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic quality of increased osteopontin (OPN) plasma levels has been demonstrated for the chemotherapy and surgery of lung cancer. There is also evidence in the literature that tumor volume impacts prognosis in definitive radiotherapy (RT) of (lung) cancer. We previously demonstrated that elevated plasma levels of OPN before, and increasing OPN plasma levels after RT significantly correlate with survival and outcome after curative-intent RT of non-small-cell lung cancer (NSCLC). Tumor volume was also associated with prognosis. The present prospective clinical study investigated the prognostic interrelation of OPN plasma levels and tumor volume and their changes in the radical RT of NSCLC. We evaluated a subset of patients (n=27) with inoperable, non-metastasized NSCLC of the previously published patient collective. Patients were treated with radical radiochemotherapy (2 Gy ad 66 Gy). OPN plasma concentrations were determined by ELISA before (t0), at the end (t1), and 4 weeks after RT (t2). GTV was delineated PET- and CT-correlated before RT (GTV1) and after 40 Gy (GTV2). The course of OPN during and after RT and the change of GTV during RT was monitored over time and correlated with prognosis. Median GTV2 after 40 Gy (63 ml) was significantly lower than pre-RT GTV1 (90 ml, P<0.0001). Median OPN before (t0), at the end of (t1) and four weeks after RT (t2) was 846, 777 and 624 ng/ml and not significantly different. GTV significantly declined by 39 ml during RT (P<0.0001) and OPN non-significantly decreased by 56 ng/ml during (t0 to t1) and by 54 ng/ml after RT (t1 to t2). No correlations were determined between absolute OPN and GTV values or their relative changes during RT. In univariate analysis, only GTV2 significantly predicted overall survival (OS, P=0.03). In multivariate analysis, both OPN t1 (P<0.001) and GTV2 (P=0.001) remained significant predictors of OS. Relative OPN plasma level changes after (t1 to t2) and GTV changes during RT (GTV 1 to GTV 2) significantly predicted OS (P=0.02). The combination of absolute GTV values before RT (GTV1) and GTV changes during RT (GTV1 to 2) were significantly associated with OS in both uni- and multivariate analysis (P=0.03). The combination of absolute OPN plasma levels and their changes with GTV and its changes did not reach statistical significance. The lack of a significant correlation between OPN and GTV together with the finding that OPN and GTV remained independent predictors of survival outcome but were not associated with OS in combination supports the hypothesis that tumor volume (GTV) and OPN plasma levels (both their changes and absolute values) are not interrelated in terms of prognosis but do possess each parameter separately, a prognostic quality in the radical RT of NSCLC which justifies further prospective studies to validate these results.
引用
收藏
页码:3449 / 3456
页数:8
相关论文
共 50 条
  • [21] Postoperative radiotherapy in non-small-cell lung cancer
    Kal, HB
    El Sharouni, SY
    Struikmans, H
    LANCET, 1998, 352 (9137): : 1385 - 1385
  • [22] Postoperative radiotherapy in non-small-cell lung cancer
    Klages, HT
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (03) : 134 - 135
  • [23] Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography
    Britton, Keith R.
    Starkschall, George
    Tucker, Susan L.
    Pan, Tinsu
    Nelson, Christopher
    Chang, Joe Y.
    Cox, James D.
    Mohan, Radhe
    Komaki, Ritsuko
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (04): : 1036 - 1046
  • [24] Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer A systematic review
    Kasmann, Lukas
    Niyazi, Maximilian
    Blanck, Oliver
    Baues, Christian
    Baumann, Rene
    Dobiasch, Sophie
    Eze, Chukwuka
    Fleischmann, Daniel
    Gauer, Tobias
    Giordano, Frank A.
    Goy, Yvonne
    Hausmann, Jan
    Henkenberens, Christoph
    Kaul, David
    Klook, Lisa
    Krug, David
    Maeurer, Matthias
    Panje, Cedric M.
    Rosenbrock, Johannes
    Sautter, Lisa
    Schmitt, Daniela
    Suess, Christoph
    Thieme, Alexander H.
    Trommer-Nestler, Maike
    Ziegler, Sonia
    Ebert, Nadja
    Medenwald, Daniel
    Ostheimer, Christian
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (02) : 79 - 90
  • [25] Radical radiotherapy for non small cell lung cancer
    Biswas, D.
    Magee, L.
    Gilligan, D.
    Harden, S.
    LUNG CANCER, 2009, 63 : S35 - S35
  • [26] Statistical modeling of tumor control probability for non-small-cell lung cancer radiotherapy
    Mu, Y.
    Hope, A. J.
    Lindsay, P.
    El Naqa, I.
    Apte, A.
    Deasy, J. O.
    Bradley, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S448 - S448
  • [27] Tumor growth and waiting times before radiotherapy of non-small-cell lung cancer
    Petersen, C
    Baumann, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (04) : 221 - 222
  • [28] The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer
    Fleckenstein, Jochen
    Jelden, Michael
    Kremp, Stephanie
    Jagoda, Philippe
    Stroeder, Jonas
    Khreish, Fadi
    Ezziddin, Samer
    Buecker, Arno
    Ruebe, Christian
    Schneider, Guenther K.
    PLOS ONE, 2016, 11 (09):
  • [29] NON-SMALL CELL LUNG CANCER (NSCLC): CHANGES IN VOLUME DURING RADIOTHERAPY AND POTENTIAL ADAPTIVE RADIOTHERAPY PLANNING
    Ho, Ge Kai
    Kumar, Shivani
    Arumugam, Sankar
    Jameson, Michael
    Degruyter, Skye
    Phan, Penny D. T.
    Holloway, Lois C.
    Vinod, Shalini
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S844 - S845
  • [30] Tumor evolution in non-small-cell lung cancer
    Parry, Marina
    ESMO OPEN, 2018, 3 (06)